Adverum Biotechnologies Stock Price History
ADVM Stock | USD 6.45 0.29 4.71% |
If you're considering investing in Adverum Stock, it is important to understand the factors that can impact its price. As of today, the current price of Adverum Biotechnologies stands at 6.45, as last reported on the 28th of November, with the highest price reaching 6.46 and the lowest price hitting 6.19 during the day. Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0154, which signifies that the company had a -0.0154% return per unit of risk over the last 3 months. Adverum Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adverum Biotechnologies' Mean Deviation of 2.66, insignificant risk adjusted performance, and Standard Deviation of 3.53 to double-check the risk estimate we provide.
Adverum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Adverum |
Sharpe Ratio = -0.0154
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ADVM |
Estimated Market Risk
3.53 actual daily | 31 69% of assets are more volatile |
Expected Return
-0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Adverum Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding Adverum Biotechnologies to a well-diversified portfolio.
Adverum Biotechnologies Stock Price History Chart
There are several ways to analyze Adverum Stock price data. The simplest method is using a basic Adverum candlestick price chart, which shows Adverum Biotechnologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 18, 2024 | 8.48 |
Lowest Price | November 21, 2024 | 5.75 |
Adverum Biotechnologies November 28, 2024 Stock Price Synopsis
Various analyses of Adverum Biotechnologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Adverum Stock. It can be used to describe the percentage change in the price of Adverum Biotechnologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Adverum Stock.Adverum Biotechnologies Price Daily Balance Of Power | 1.07 | |
Adverum Biotechnologies Price Rate Of Daily Change | 1.05 | |
Adverum Biotechnologies Price Action Indicator | 0.27 |
Adverum Biotechnologies November 28, 2024 Stock Price Analysis
Adverum Stock Price History Data
The price series of Adverum Biotechnologies for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 2.73 with a coefficient of variation of 8.54. The prices are distributed with arithmetic mean of 7.27. The median price for the last 90 days is 7.3. The company had 1:10 stock split on 21st of March 2024.Open | High | Low | Close | Volume | ||
11/28/2024 | 6.22 | 6.46 | 6.19 | 6.45 | ||
11/27/2024 | 6.22 | 6.46 | 6.19 | 6.45 | 292,341 | |
11/26/2024 | 6.13 | 6.20 | 5.98 | 6.16 | 133,219 | |
11/25/2024 | 6.13 | 6.33 | 6.10 | 6.15 | 206,290 | |
11/22/2024 | 5.75 | 6.15 | 5.69 | 6.04 | 452,190 | |
11/21/2024 | 6.11 | 6.16 | 5.70 | 5.75 | 873,726 | |
11/20/2024 | 6.26 | 6.34 | 6.00 | 6.17 | 221,338 | |
11/19/2024 | 6.86 | 6.90 | 6.14 | 6.25 | 623,105 | |
11/18/2024 | 7.30 | 7.73 | 6.85 | 6.85 | 413,032 | |
11/15/2024 | 7.29 | 7.29 | 6.81 | 6.86 | 233,650 | |
11/14/2024 | 7.64 | 7.64 | 7.23 | 7.25 | 204,388 | |
11/13/2024 | 7.90 | 8.05 | 7.53 | 7.56 | 124,399 | |
11/12/2024 | 7.79 | 7.97 | 7.59 | 7.89 | 202,229 | |
11/11/2024 | 8.18 | 8.18 | 7.75 | 7.76 | 147,086 | |
11/08/2024 | 7.91 | 8.06 | 7.83 | 8.00 | 126,243 | |
11/07/2024 | 7.98 | 8.12 | 7.87 | 7.90 | 110,736 | |
11/06/2024 | 8.02 | 8.08 | 7.76 | 7.94 | 187,667 | |
11/05/2024 | 7.53 | 7.77 | 7.26 | 7.72 | 104,786 | |
11/04/2024 | 7.49 | 7.73 | 7.30 | 7.54 | 127,563 | |
11/01/2024 | 7.32 | 7.51 | 7.17 | 7.41 | 175,843 | |
10/31/2024 | 7.90 | 7.90 | 7.29 | 7.30 | 130,288 | |
10/30/2024 | 7.74 | 8.07 | 7.71 | 7.88 | 187,501 | |
10/29/2024 | 7.96 | 8.01 | 7.62 | 7.76 | 171,035 | |
10/28/2024 | 8.02 | 8.20 | 7.86 | 7.92 | 235,538 | |
10/25/2024 | 8.21 | 8.21 | 7.90 | 7.98 | 92,368 | |
10/24/2024 | 8.17 | 8.27 | 8.03 | 8.08 | 97,137 | |
10/23/2024 | 8.02 | 8.27 | 7.90 | 8.12 | 142,661 | |
10/22/2024 | 8.28 | 8.33 | 8.08 | 8.14 | 183,046 | |
10/21/2024 | 8.44 | 8.53 | 8.18 | 8.26 | 211,367 | |
10/18/2024 | 8.08 | 8.56 | 8.02 | 8.48 | 166,708 | |
10/17/2024 | 8.20 | 8.30 | 7.93 | 8.08 | 198,190 | |
10/16/2024 | 7.79 | 8.21 | 7.77 | 8.21 | 242,261 | |
10/15/2024 | 7.72 | 7.86 | 7.56 | 7.69 | 149,985 | |
10/14/2024 | 7.65 | 7.85 | 7.44 | 7.73 | 168,092 | |
10/11/2024 | 7.44 | 7.67 | 7.40 | 7.65 | 134,275 | |
10/10/2024 | 7.42 | 7.47 | 7.20 | 7.44 | 134,502 | |
10/09/2024 | 7.56 | 7.86 | 7.32 | 7.52 | 214,918 | |
10/08/2024 | 7.41 | 7.91 | 7.41 | 7.61 | 126,259 | |
10/07/2024 | 7.57 | 8.14 | 7.40 | 7.44 | 335,636 | |
10/04/2024 | 7.41 | 7.70 | 7.19 | 7.53 | 381,494 | |
10/03/2024 | 6.79 | 7.49 | 6.71 | 7.28 | 191,539 | |
10/02/2024 | 6.53 | 7.03 | 6.53 | 6.82 | 1,014,555 | |
10/01/2024 | 6.95 | 6.99 | 6.54 | 6.59 | 214,405 | |
09/30/2024 | 6.90 | 7.11 | 6.90 | 7.02 | 76,161 | |
09/27/2024 | 6.73 | 7.08 | 6.66 | 6.94 | 108,786 | |
09/26/2024 | 6.66 | 6.77 | 6.52 | 6.61 | 128,769 | |
09/25/2024 | 6.95 | 7.03 | 6.57 | 6.59 | 135,281 | |
09/24/2024 | 6.91 | 7.11 | 6.87 | 6.94 | 289,044 | |
09/23/2024 | 7.48 | 7.48 | 6.88 | 6.88 | 160,640 | |
09/20/2024 | 7.42 | 7.69 | 7.38 | 7.49 | 281,932 | |
09/19/2024 | 7.12 | 7.66 | 7.12 | 7.50 | 231,419 | |
09/18/2024 | 7.30 | 7.42 | 6.97 | 6.99 | 342,887 | |
09/17/2024 | 7.30 | 7.67 | 7.14 | 7.30 | 180,075 | |
09/16/2024 | 7.29 | 7.49 | 7.16 | 7.21 | 176,159 | |
09/13/2024 | 7.11 | 7.38 | 7.05 | 7.23 | 99,834 | |
09/12/2024 | 7.05 | 7.22 | 6.93 | 7.05 | 133,926 | |
09/11/2024 | 7.14 | 7.18 | 6.90 | 7.03 | 105,328 | |
09/10/2024 | 7.00 | 7.20 | 6.90 | 7.18 | 93,586 | |
09/09/2024 | 6.78 | 7.07 | 6.77 | 6.96 | 124,457 | |
09/06/2024 | 6.81 | 6.83 | 6.54 | 6.76 | 101,887 | |
09/05/2024 | 6.87 | 7.00 | 6.66 | 6.82 | 112,941 |
About Adverum Biotechnologies Stock history
Adverum Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adverum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adverum Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adverum Biotechnologies stock prices may prove useful in developing a viable investing in Adverum Biotechnologies
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California. Adverum Biotechnlgs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people.
Adverum Biotechnologies Stock Technical Analysis
Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Adverum Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adverum Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adverum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adverum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.24) | |||
Total Risk Alpha | (0.60) | |||
Treynor Ratio | (0.04) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.